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Abstract: We develop an index that compares the quality of Patent Cooperation 
Treaty (PCT) applications by considering citations generated by International Search 
Reports (ISRs). In its most restrictive variation, i.e. excluding citations from the home 
country and self-citations, the ISR index is not biased by selectivity in filing strategies, 
differences in citations due to varying national examination procedures, or domestic 
economic policies. Against the background of strong increases in Chinese patenting 
between 2001 and 2009, we compare the quality of Chinese PCT applications with 
those from high-income countries. Chinese PCT applications achieve only 34% of the 
quality level of international PCT applications. In addition, their quality is decreasing 
over time. We find that the patent quality of firms increases in R&D stocks but 
decreases with the introduction of PCT subsidies. Our results confirm that China’s 
expansion of international filings was achieved to the detriment of quality. 
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1 Introduction  
The current globalization of R&D activities is reflected in international patenting. Between 
1995 and 2013, the number of global patent applications at national offices increased from 
below one million to 2.4 million, whereas the share filed within the triadic region – the United 
States Patent and Trademark Office (USPTO), Japanese Patent Office (JPO), and European 
Patent Office (EPO) – declined from 69% to 49% in the same time period (OECD 2015). 
These trends reflect both a strong demand for patent protection and a decentralization of 
inventive activities away from the triadic region, which traditionally hosted most global R&D. 
Although the international protection of intellectual property is rising, this protection is no 
longer focused on the triadic region. The 414% increase in the number of Patent Cooperation 
Treaty (PCT) applications between 1995 and 2013 is disproportionately large in comparison 
to that of triadic patent families, which increased by a mere 43% over the same time period 
(OECD 2015).  
Due to R&D globalization and the rapidly increasing quantity of patent applications 
from emerging countries like China, international comparisons of patent quality is growing in 
relevance. However, as we argue in this paper, there currently exists no satisfactory measure 
to provide concluding evidence. Addressing this gap, we develop a novel measure and apply 
it to investigate the quality of China’s rapidly rising PCT applications in comparison to an 
international benchmark. 
Prior literature has proposed that the count of triadic patent families at the country or 
firm level can function as a quality measure to be used in international comparisons (Grupp 
and Schmoch 1999). Patents filed at the USPTO, the JPO, and the EPO are considered to be 
the most valuable patents as the granting process is demanding and expensive. However, this 
measure is crude – significant quality variation exists among different triadic patents and is 
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not captured by a mere count. The declining relative importance of the triadic region only 
further diminishes the relevance of this measure.  
Alternative quality measures are most commonly based on citations. An advantage of 
these measures is their ability to allow for different quality levels within a set of patents. 
However, these measures are problematic if they are based on citations from just one patent 
office, because patent examiners are typically biased in favor of citing applications from their 
own countries in search reports (Michel and Bettels 2001). Consequently, single patent office 
citations measures are not useful for international comparisons. Even if citations from all 
major patent offices are accounted for, clear cross country comparisons are impossible if 
analysis is restricted to applications from a single patent office. This is because applications 
from different countries are not fully comparable: they constitute domestic applications for 
local applicants but international applications for foreign applicants. There is a positive 
selection bias for international applications because firms select only their more valuable 
inventions for protection abroad. Further quality measures proposed in the literature are the 
grant rate and the renewal rate. However, these indicators can potentially be influenced by 
domestic economic policy, e.g. as observable in China, which restricts their applicability for 
international comparisons. 
Addressing these limitations, we develop a novel index based on citations generated 
by the International Search Reports (ISRs) of PCT applications. The index compares the 
number of ISR citations received by a set of applications from one country to the number of 
ISR citations received by applications of the same priority year and technology class from 
other countries. An ISR index of 100% signifies a quality level just equal to the average 
international application quality.  
PCT applications are filed with a competent Receiving Office (RO). During the 30 
months following the priority date, a PCT application is in the international phase. The 
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designated International Search Authority (ISA) publishes the ISR 18 months after priority. 
References to prior art are contained in the ISR, and the strict PCT guidelines for these 
references are identical for all ISAs. After 30 months, the application enters the national phase 
in which national patent offices perform additional search and examination and ultimately 
make the grant decision.  
In its most restrictive form, the ISR index is designed to rely as much on foreign and 
regulatory oversight as possible. Therefore we exclude citations from the home country of the 
focal patents as well as self-citations. Focusing on citations originating from the PCT system 
simplifies international quality comparisons for three reasons. First, selection bias is avoided 
as, irrespective of the applicant’s home country, PCT filings are always international 
applications. Second, the PCT system subjects applications from different countries to the 
same procedures. The ISR index is thus not influenced by differing practices at domestic 
patent offices. Third, distortions by governmental intervention are avoided because the quality 
measure cannot be influenced by the economic policy of the focal country. In two less 
restrictive variations of the index we investigate changes depending on the inclusion of 
citations from the own country as well as self-citations.  
Motivated by the tremendous increase in Chinese PCT applications after 2001 
(Figure 1), we apply our index to study the quality of these applications. As firms typically 
face a tradeoff between the quality and quantity of their applications (de Rassenfosse 2013), 
China’s dramatic patent expansion has elicited questions regarding patent quality. China’s 
patent expansion follows quantitative targets set by governmental economic policies.1  In 
consideration of these targets, numerous provincial and sub-provincial subsidy programs 
incentivize patenting, and they commonly support domestic as well as international 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
1 Recent cornerstones of China’s innovation policy are the “Medium- to Long-term Plan for Science and 
Technology Development (2006-2020)” (MLP), the “National Patent Development Strategy (2011-2020),” and 
complementary “Five-Year Plans for Science and Technology Development.” 
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applications. In addition, the central government introduced subsidies for granted PCT patents 
in 2009 (Ministry of Finance 2009).  
Investigating the effect of patent subsidies on China’s patent expansion, Li (2012) 
documents a positive relationship. Lei et al. (2012) confirm this finding but show that the 
number of claims per applicant remains constant whereas the resulting number of claims per 
patent decreases in response to increases in subsidies. Because this suggests that increases in 
patents do not reflect increases in inventions (as measured by claims), it is surprising that 
resulting decreases in average patent quality are not reflected in decreasing grant rates. 
Instead, both studies report constant or even increasing grant rates. Consequently, it seems 
that China’s economic policy not only increases the number of patent applications but also 
lowers examination standards – making grant rates an unreliable measure for patent quality.2  
Against this background, China’s State Intellectual Property Office (SIPO) has 
recently published two documents that criticize the abundance of provincial and city-level 
subsidies for patent applications and low examination standards at provincial and city-level 
patent offices (SIPO 2014, 2013). SIPO suggests that increases in applications are detrimental 
to average patent quality, and it demands stricter monitoring practices of examination 
standards. Further, SIPO proposes to change application-based subsidy schemes to grant 
based ones and thereby to reduce excessive applications while incentivizing patent quality 
over quantity. Hence, a reliable analysis of the quality of Chinese patents is of great interest to 
practitioners and academics.  
In the application of the ISR index, we start with an analysis of PCT application data 
based on the April 2013 version of the international patent database PATSTAT and consider 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
2 The effect of China’s economic policy on examination standards may be direct, if provincial policy makers 
encourage constant grant rates, or indirect, if examiners are confronted with increasing applications – leading to 
considerably shortened examination periods that are negatively correlated with the probability of discovering 
prior art. 
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applications where the first applicant is from China for the country-wide analysis. In a 
separate step, the full patent data is matched to data on the population of listed firms in order 
to extend the analysis from the country to the firm level. For our most restrictive index (non-
self citations from outside own-country) we find that for the priority years 2001-2009, the full 
set of PCT applications with Chinese origin achieves a quality level of only 34% of the 
quality level of international PCT applications. Furthermore, patent quality is strongly 
decreasing over time. In contrast, the most inclusive index (citations from own-country and 
self-citations) shows an increase in quality, with quality surpassing the international 
benchmark in the later years. These divergent results can be explained by the increasing size 
of the Chinese patent system (through which earlier patents become more likely to be cited) 
and the growth of self-citations prompted through Chinese firm growth. At the firm level, we 
only observe a significant relationship between R&D stock and the most restrictive index 
whereas firm size plays a role for the least restrictive form. These results highlight the need 
for utmost precision when selecting the set of citations to be considered for quality 
evaluations. 
The ISR index has a broad applicability beyond the scope of applications in this paper. 
In its most restricted form, the index provides a clear quality assessment regardless of 
economic and political influences from the focal country. As such, it is highly suitable for 
policy analysis. Depending on the researcher’s analytical focus, it is possible to include a 
wider set of citations, e.g. from the focal country or self-citations. The index is equally 
applicable to countrywide analysis, analysis of a sub-group of applicants (e.g. universities), 
analysis of a single applicant (e.g. a large multi-national firm), and even to the analysis of 
single applications. 
The remainder is structured as follows. Section 2 develops our quality index, Section 3 
describes the prior literature on the quality of Chinese patents and explains the application of 
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the index to the Chinese setting, Section 4 introduces data sources, Section 5 presents the 
analysis, and Section 6 concludes. 
2 Index development 
2.1 Definition of the ISR index 
In this section we introduce an index that allows for cross-country comparisons of patent 
quality. We define this index in three variations, all of which together deepen our 
understanding of the considered inventions. In order to achieve a high comparability between 
countries, we only consider citations generated by PCT applications during the stage of 
international search, i.e. the citations mentioned in the ISR. PCT applications are 
characterized as filing strategies with identical legal backgrounds independent of the 
applicant’s country of origin and are comparable because they represent international 
applications for all firms (Grupp and Schmoch 1999). Due to high filing costs, organizations 
typically file only a selection of their inventions for international protection. Thus, the index 
is based on an evaluation of the most valuable inventions of each country.  
Below we provide the formula for the most restrictive form of the index. The indicator 
non-self citationi,j is equal to one if application i is cited by application j within the defined 
time window and zero otherwise. i, j, k are a specific PCT application with I the total number 
of applications. c is the country of the first applicant, t is priority year, and m is technology. 
c’, t’ and m’ denote a specific country, year, and technology, respectively. Nt’, m’, c’ is the 
number of PCT applications with priority year t’, technology m’, and country c’. 
For the comparison of the quality of a set of patents from year t’, technology m’, and 
country c’ with an international quality benchmark, we define the following formula: 
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Thus, our index compares the average number of non-self citations from ISRs received 
by PCT applications of country c’ to the average number of such citations received by PCT 
applications of the other countries.  
The most restrictive of the three variations of the index uses only non-self citations 
emanating from ISRs of applicants from outside of the focal country. To avoid any national 
biases, we exclude citations if the applicants of citing and cited patent are from the same 
country. Due to technological specialization of countries, applicants may receive a 
disproportionate share of citations from their home country. This exclusion procedure also 
ensures that the citation count is independent of the size of the home economy; likewise, 
citation count is independent of trends in application numbers of the home patent system. 
Furthermore, we exclude self-citations from our citation count to only measure the use of an 
invention by a third party. To avoid double counting, only citations from distinct family pairs 
of citing and cited patents are considered. Fractional counting is used to apportion patents that 
belong to more than one technology class. A value of the ISR index of larger (smaller) than 
100% signifies quality above (below) the international benchmark. 
The first extension of the index includes citations from PCT filings of the home 
country, and it thereby reflects the degree to which the economy builds on its own research as 
compared with benchmark countries. The second extension additionally accounts for self-
citations. Larger values of this latter extension are expected for economies dominated by large 
individual applicants. 
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2.2 Advantages of using PCT citations to measure quality 
We follow prior literature by choosing citations as a proxy for the economic value and thus 
the quality of patents. Citations have been shown to be a good proxy for both the economic 
value (Harhoff et al. 1999) and the technological value (Trajtenberg 1990) of patents. 
However, they are not an indicator of the legal quality of the draft of the application. 
Considering survey responses for the actual economic value of patents, Gambardella et al. 
(2008) show that citations have a closer relationship to value than references, claims, or 
family size – other proxies typically available in large-scale analyses. In addition, citations are 
available from many patent offices. The length of the renewal period is an alternative quality 
measure, but its international comparability is limited due to differences in renewal fees. 
Finally, legal procedures called oppositions, while good quality measures, are not available in 
all jurisdictions.  
Even though citations are generally a credible quality measure, citation counts can be 
difficult to compare across countries. In applications with an international context one has to 
consider different practices in national patent offices. For a set of triadic patent families, 
Michel and Bettels (2001) show that the USPTO cites three-times more patent references than 
the EPO when examining these families according to the national standard. In contrast, the 
authors demonstrate very similar citation rates for USPTO, EPO, and the JPO when the 
offices prepare ISRs as ISAs, and they therefore conclude that comparative studies have an 
advantage if they draw their citation data from only one legal system. We follow their advice 
and base our quality measure only on citations from the ISRs of PCT applications.  
Further differences among patent offices are due to differing rules for applicant 
citations. Whereas in the US the applicants need to provide references to all relevant prior art 
they are aware of, the EPO requires only the examiner – not the applicant – to perform this 
task (Michel and Bettels 2001). With respect to applicant citations, the rules of the PCT 
system are in between the extremes of USPTO and EPO. The description of the application 
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should “indicate the background art which, as far as known to the applicant, can be regarded 
as useful for the understanding, searching and examination of the invention, and, preferably, 
cite the documents reflecting such art” (Rule 5 of WIPO 2014c).3 Ultimately, the examiner 
controls which references are included in the search report. The selected references measure 
the technical and legal relationship among patents and are the appropriate measures of patent 
value for our analysis. 
Restricting the analysis to citations from the ISR has several advantages. The PCT 
system applies common standards for the search of prior art, which makes the citations 
internationally comparable regardless of the nationality of the ISA conducting the search. The 
search guidelines explain in detail how citations should be selected by the examiners (WIPO 
2014b, §15.63-15.67). For example, examiners are encouraged to cite only the most relevant 
documents and to cite documents in the language of the application, if several members of 
one patent family are available (WIPO 2014b, §15.64). As we aggregate citations at the 
family level, our quality index is not influenced by which family member is actually cited. 
International comparability is further enhanced because the search for prior art is highly 
concentrated among few ISAs. According to WIPO (2014a, p. 69), the top five ISAs were 
responsible for more than 90% of ISRs in 2013 (EPO 37.7%, JPO 20.7%, SIPO 11.6%, 
Korean Patent Office (KPO) 14.8%, USPTO 8.1%). 
PCT applications move from the international to the national phase 30 month after 
priority. National patent offices conduct additional searches and examine the application 
before deciding a grant. Citations in the national phase can differ from ISR citations as they 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
3 Analyses of knowledge flows should only consider applicant references as there is a higher likelihood that the 
inventors are aware of them (see Alcácer and Gittelman 2006 for differences between the two types of 
references). As we are not interested in the measurement of knowledge flows, the difference between applicant 
and examiner citations are of second order to us and we therefore include both types of citations. 
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follow national guidelines. In order to restrict the citations to one institutional setting, we do 
not consider citations generated during the national phase for our quality index. 
In international comparisons, one must account for potential language barriers that 
deter patent examiners from identifying prior art from a specific country. Patent examiners 
typically start their search for prior art with a keyword search in English, regardless of which 
searches – i.e. searches for the ISR or searches within national procedures – are conducted. 
Thorough prior art searches are only possible if documents published in other languages can 
be found. The PCT system provides an English translation of the main parts of PCT 
applications, namely title, abstract, international search report, and any text relating to figures 
for all PCT applications not published in English (WIPO 2014c, Rule 48.3 (c)). Concerning 
search, the abstract plays a key role. According to Rule 8.3 (WIPO 2014c) “The abstract shall 
be so drafted that it can efficiently serve as a scanning tool for purposes of searching in the 
particular art, especially by assisting the scientist, engineer or researcher in formulating an 
opinion on whether there is a need for consulting the international application itself”. PCT 
applications, even if not originally published in English, are therefore easily identifiable as 
potentially relevant prior art. It remains to be discussed in our application example (Section 4) 
whether the availability of the full text of the patent document in English makes difference to 
actual citation rates. In any case, if the quality of national applications should be compared 
with our index, one has to consider whether language biases exist. If yes, one should try to 
quantify those.  
According to further guidelines of the PCT system, patent examiners conducting the 
international search have to have access to the minimum documentation standard, which 
specifies which prior art needs to be searchable for examiners. PCT applications, no matter of 
which publication language, are part of this minimum standard. As such, all PCT applications 
are fully available during the search process. Patent applications belonging to the minimum 
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documentation standard are typically included in the databases most commonly used for 
search by examiners (e.g. Derwent World Patents Index (DWPI), Chemical Abstracts Service 
(CAS), and EPOQUE at the EPO). When applying our index, one must ensure that the set of 
focal patents to be analyzed is contained in the minimum documentation standard. For 
example, Chinese domestic applications with SIPO are only included in the minimum 
documentation standard since 2012. 
3 Application to China 
3.1 Prior literature on the quality of Chinese patents 
Before we use our index to compare the quality of Chinese patents to an international 
benchmark, in this section we discuss relevant prior literature. Although existing studies have 
approached the topic of patent quality in China from different angles, these studies suffer 
from several limitations. One method compares the quality of domestic and foreign filings at 
SIPO. Using renewal decisions as a quality measure, several papers find that patents of 
Chinese applicants are less valuable than those of non-Chinese applicants. For the time period 
1985-2009, Gupeng and Xiangdong (2012) observe that patents from domestic applicants 
typically reach only 33%-50% of the value of patents from foreign applicants. The authors 
rely on the method used by Schankerman and Pakes (1986) to relate renewal decisions to 
patent value, and they extend this method to patents that are still in force. Taking possible 
infringement into account, Zhang et al. (2014) find that domestic applicants reach 40%-60% 
of the value of patents of foreign applicants. According to Huang (2012), the value gap has 
narrowed in the 2000s. Ultimately, the quantification of the value differences is problematic 
on two fronts. On one hand, positive selection bias distorts quality results. That is, the 
measured quality advantage of foreign applicants is in fact overestimated because applicants 
seek protection abroad only for their more valuable applications (Harhoff et al. 2003). On the 
other hand, economic policy might encourage applicants to hold a large active patent portfolio 
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to restrict entry by foreign firms (Herrmann-Pillath 2014, 414-416). Renewal decisions are 
therefore based not only on economic considerations but also on political incentives, and thus 
value estimates are inflated. In this example, economic policy may directly influence the 
chosen quality measure. Prior studies have not used Chinese citations as data on citations is 
not disclosed by SIPO. 
A different approach was chosen by Branstetter et al. (2013) who concentrate on 
grants at the USPTO from different provenances. The authors first highlight that 
approximately two thirds of USPTO grants with at least one inventor from China are filed by 
non-Chinese multi-national companies (MNCs). Using the number of citations as a quality 
measure, the authors find that purely domestic patents are of lower quality than patents filed 
by non-Chinese MNCs or with contributions by non-Chinese inventors. Whereas the paper 
clearly advances our understanding of the patent quality with respect to different economic 
actors in China, it does not provide a systematic analysis of quality differences between 
domestic Chinese firms and their international counterparts. Patent quality of MNCs could be 
systematically higher than patent quality of non-MNCs, and patents with international 
inventor teams may be of higher value because they can draw on a richer knowledge base.  
Kwon et al. (2014) also investigate the comparative quality of filings at the USPTO. 
Using the number of received citations and the share of patents with at least one citation as a 
quality measure, the authors observe that grants of Chinese origin were of lesser quality than 
those originating in the US between 1980 and 1999; however, this quality margin dissipated 
between 2000 and 2009. In addition, grants from China do not yet reach the technology 
frontier as they cite on average older US patents than US firms. Because this paper determines 
the country of origin according to the location of the first inventor, filings from non-Chinese 
MNCs are included in Chinese filings. Presumably, this measurement technique contributes to 
the observed equalization of Chinese and US grant quality in the latter time period. 
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Furthermore, the positive selection bias of foreign filings favors Chinese grants in this 
analysis.  
Finally, Thoma (2013) compares the quality of Chinese and non-Chinese applications 
at the EPO and finds shorter renewal periods, more supplementary search reports, more 
oppositions, but no difference in grant probability for indigenous R&D – defined as patents 
with at least one applicant and one inventor based in China – over the period 2000-2007. As 
indigenous R&D includes non-Chinese MNCs with locations in China and as there is a 
positive selection bias for filing at a faraway patent office, shorter renewal periods indicate 
the lower quality of patents with origin in China. The analysis does not quantify these quality 
differences, and it is not restricted to purely domestic applicants – i.e. patentees considerably 
influenced by Chinese economic policy. 
3.2 The Chinese setting 
Our quality index derived in this paper helps overcome the aforementioned limitations of 
prior quality measures. It provides an unbiased and most homogeneous comparison of patent 
quality across countries. By applying this index to the full set of Chinese PCT applications as 
well as to the set of PCT applications of listed, domestic firms, we are able to establish the 
quality level based on the comparison of the number of ISR citations received by PCT 
applications of Chinese origin to the number of ISR citations received by PCT applications 
from other countries. We evaluate both the full set of PCT filings with Chinese origin and a 
selection of PCT filings applied for by Chinese listed firms. 
Non-Chinese PCT applications are taken to constitute the international technology 
frontier because they originate mostly from high-income countries. In 2013, 87% of PCT 
applications came from high-income countries, 12% from upper-middle-income countries 
(thereof 10% from China) and only 1% from lower-middle-income countries. For the 
calculation of our benchmark we include applications from all applicant types (firms, 
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universities, and individuals). We use the same benchmark for the set of all Chinese PCT 
applications and for the PCT applications of listed firms. Because 85% of all global PCT 
applications originate from firms, we are confident that the international quality level of firms 
is reflected in the benchmark. 
For Chinese applicants the PCT procedure stipulates that they have to file PCT 
applications with SIPO as Receiving Office (RO). SIPO is also the only competent office to 
act as ISA and to write an International Preliminary Examination Report (IPER).  
The application of the index requires a choice for the citation window. When choosing 
the length of the citation window one faces a tradeoff. A long window means more 
subsequent patents have the possibility to cite and therefore the citation count will be a more 
precise measure of value. However, a shorter window allows the assessment of more recent 
patents. We choose a 3-year time period for the citation window because the Chinese 
economy shows a very dynamic development. 4  For the classification into different 
technologies we choose the 3-digit level of the IPC classification. 
When applying the index to a specific setting, one has to make sure that it is not 
influenced by aspects outside the realm of quality. In our case this applies to potential 
language barriers. As Chinese PCT applications can be published in Chinese, a language 
which is not understood by the majority of patent examiners, we need to investigate whether 
there is a possible bias against citing Chinese PCT applications as prior art, and if yes, to try 
to quantify the corresponding language bias.  
For the ultimate decision of whether to include a document as prior art, patent 
examiners want to consult the full text of the application. Examiners at ISAs have multiple 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
4 The correlations between the 3-year and the 5-year citation counts for the variations of our index are with 0.81-
0.90 relatively high. We are therefore confident that the shorter time period already gives a quite precise measure 
of quality. Furthermore, citations counts restricted to ISR citations are highly correlated with citation counts 
additionally including citations from the national phase: the correlation coefficients are around 0.8 and citation 
counts almost double. The ISR indices achieve a high information content even though citations are taken from 
just one institution. 
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sources of help available when encountering prior art in Chinese. At the EPO, for example, as 
a first line of immediate support, examiners can call on colleagues that are native speakers of 
Chinese for identifying whether a document is relevant. If the document is relevant, 
examiners can request a human translation of the full text. Machine translation of Chinese 
documents has become an intermediate step prior to requesting a human translation since 
2008. For example, since April 2008, SIPO provides free machine translation of the full text 
of its patents to the public through its website (Kaemmer 2010). Only since 2012, after our 
sample period, could examiners at the EPO machine translate documents from Chinese into 
English through their search system EPOQUE. 
By conducting interviews with patent examiners of several patent offices, we tried to 
identify possible biases against citing prior art in Chinese. When encountering Chinese prior 
art, examiners first try to find an equivalent document in English. In their decision whether 
this prior art is relevant, examiners are not influenced by their familiarity with the country or 
applicant. Importantly, it was acknowledged by a subgroup of examiners that under time 
pressure prior art in Chinese could have a lower probability to be included in the search 
report. The same could be true if alternative documents in English are readily available and 
sufficient to negate a claim or to reject an application as a whole.  
Thus, we must quantify any downward bias that might affect our quality index. In the 
following, we derive a back-of-the-envelope calculation of the size of a potential bias. During 
our sample period of 2001-2009, the majority (91%) of PCT applications of Chinese 
applicants are published in Chinese with the remainder 9% published in English. However, 
when considering English equivalents published before or at the same time as the PCT 
application, only 44% of PCT applications of Chinese origin are not available with an 
equivalent full text in English. These applications are the candidates for a language bias. On 
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average, these PCT applications receive an English equivalent after 664 days after 
publication. 
In order to quantify the actual citation bias, we calculate the share of non-self citations 
from outside China to all non-self citations before and after an English equivalent is 
available.5 As this share increases from 31% to 69%, we need to adjust our citation count by 
38% for the PCTs without English equivalents during the full citation window. We do not 
apply the adjustment for PCTs with English equivalents at publication, and we weigh the 
adjustment factor by 664/1095 for PCTs that obtain an English equivalent during the citation 
window, as the full 3-year citation window has a length of 1095 days. Thus, we arrive at a 
weighted correction factor of 11%. Even though the size of the language barrier is substantial 
for affected applications, the overall effect is smaller as not all applications are affected or are 
not affected over the full citation window. We will come back to the correction factor of 11% 
when interpreting our results. As it takes time for knowledge to diffuse geographically (Jaffe 
et al. 1993, Peri 2005), an increase of foreign citations is expected purely on technological 
grounds. The calculated correction factor is therefore an upper limit for the language bias.6 
4 Data and descriptive statistics 
For the subsequent analysis we construct two panel datasets, one at the patent level and one at 
the firm level. Our patent data is accessed via the EPO Worldwide Patent Statistical Database 
(PATSTAT, version October 2013). For the development of the quality index we consider the 
global population of PCT applications with a priority date between 2001 and 2009. Country 
allocation of PCT applications takes place according to the country of the first applicant. We 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
5 Self-citations from outside China are possible in general, if an international subsidiary of a Chinese firm cites 
inventions of its mother company. 
6 More detailed investigation of how publication languages influence the identification of prior art in search 
reports is a worthwhile topic for future research but is beyond the scope of our analysis.  
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use the DOCDB standard names available in PATSTAT and the applicant name 
harmonization from KU Leuven (EEE-PPAT) to identify self-citations among PCT 
applications of the same applicant.  
In the first dataset we observe the population of 34,738 Chinese PCT applications filed 
between 2001 and 2009. The time period starts in 2001 as Chinese PCT applications before 
2001 are a rare event (see Figure 1). The time period ends in 2009 as the 3-year citation 
window opens 18 months after application and restricts the inclusion of more recent years. 
Against a continuous annual increase in application numbers from 793 to 9,641 over our time 
period, we observe a noticeable jump after 2008 – coinciding with the introduction of 
subsidies for PCT grants in China. 
Our firm data covers the population of domestic Chinese firms listed at one of the two 
stock exchanges in Shanghai and Shenzhen over the time period 2001-2009. 7  Due to 
governmental stock issuance quotas, listed firms are adequately representative of the 
industrial composition of China’s economy, with a high representation of large manufacturing 
firms located in China’s more developed Coastal region (Pistor and Xu 2005). Note that the 
China Securities Regulatory Commission only allows listings of ‘domestic’ Chinese firms, 
e.g. the percentage of total shares held by foreign parties must not exceed 20%. This implies 
that patents from non-Chinese MNCs are excluded from our analysis of firm patents. We 
access firm data from Compustat, Datastream, and the Chinese databases WIND and 
RESSET. In addition, we derive firms’ patent applications with SIPO from PATSTAT to 
complement PCT applications with domestic applications. Patent and firm data is matched 
according to the procedure specified in Boeing et al. (2015). Data on provincial GDP per 
capita is accessed from China’s National Bureau of Statistics. 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
7 Data on Chinese listed firms has been widely used in high-quality publications (for examples see Fisman and 
Wang 2010, Kato and Long 2006, and Fernald and Rogers 2002). 
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We briefly summarize standard firm characteristics for 228 firms with PCT 
applications for which we have 451 observations (Table 1). Employing the perpetual 
investment method, we calculate deflated R&D stocks based on an assumed 20% annual 
growth rate of R&D and the standard rate of 15% annual depreciation. The resulting median 
R&D stock has a value of 30 million RMB. The PCT and domestic patent stocks include the 
firms’ complete applications, depreciated by 15% annually. To adjust for differences in firm 
size, we scale patent stocks by employees (in thousands) and find that the ratio is much 
smaller for PCT than for domestic applications. Firms with PCT applications are relatively 
large, with a median employment of 3,126. We broadly differentiate between firms with and 
without any government ownership and find that, according to this definition, 42% of 
observations are private firms. Figure 2 provides information about the expansion of patent 
ownership over time. In comparison to a 19% annual growth rate for the number of firms with 
at least one domestic application, the growth rate for number of firms with PCT applications 
and – more restrictively – with PCT applications that receive at least one citation from an ISR 
is larger, with 31% and 35% respectively. This analysis shows that during our observation 
period Chinese firms were still catching up with respect to ownership of international patents.  
5 Analysis of patent quality 
5.1 PCT applications of Chinese origin 
Firstly, we discuss our most restrictive index, which considers non-self citations from outside 
own-country (ISR index 1). Of all Chinese PCT applications, only 6.0% are cited within a 3-
year window. The average Chinese PCT application receives 0.08 citations over this time 
period (see Table A1 in the Appendix for detailed information). In combination with the 
citation rate of 0.25 for non-Chinese PCT applications, we arrive at a mean value of 0.34 for 
the quality index (Table 2). Even if we apply the 11% correction factor for potential language 
bias to the quality index, the corrected index of 0.37 suggests a quality level well below the 
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international benchmark (parity with the benchmark would imply an index value of one). 
Furthermore, our results show a strong decline in quality from 0.48 to 0.34. This decline is 
caused by a significant decrease in citations received by Chinese PCT applications – from 
0.13 to 0.06 – and not by an increase in the international benchmark, which remains very 
stable over time. 8  Our results are highly relevant for a better understanding of the 
technological progress of China. The country experienced an impressive increase in the 
number of PCT applications, but restricting attention to a simple count measure is not enough. 
When comparing the technological progress of countries, the quality of applications must be 
considered as well. If Chinese PCT applications were weighted with their quality, a smaller 
growth rate of technological progress would obtain. 
Secondly, we focus on the quality index that excludes self-citations but considers 
citations from the own-country (ISR index 2). Given this indicator, 15.5% of Chinese PCT 
applications are cited. Average citations of a Chinese PCT application increase to 0.22 and 
non-Chinese PCT applications receive 0.37 citations. Consequently, the mean quality index is 
calculated as 0.63. This sizable increase with respect to the former measurement may be 
attributed to the rapid expansion of Chinese PCT applications and the related increase in 
citations received from the own country.  
Finally, we focus on the most inclusive index, which considers citations from the 
applicant’s own country and self-citations (ISR index 3). In this specification, an even higher 
share of Chinese PCT applications – 28.8% – is cited. The average Chinese PCT application 
receives 0.44 citations. In combination with 0.50 citations for a non-Chinese PCT application, 
we arrive at a mean value of 0.91 for the quality index – close to average international quality. 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
8 95% of non-Chinese PCT applications originate from only 18 countries. If one would use these countries 
separately as a benchmark, the benchmark would increase in six cases, be constant in 11 cases, and decrease in 
one case. Because the citation count of the benchmark is weighted to mirror the technological composition of the 
target country, it is not identical to the quality of the average application of the country. The analysis of the 
quality development of patents from other countries is left for future research. 
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Turning attention to the development over time, in 2008 the index exceeds the quality level of 
the international benchmark for the first time. This finding suggests that in recent years 
Chinese applicants have increased self-citations more than non-Chinese applicants.  
In effect, our least restrictive index combines two developments: one is the expansion 
of the Chinese patent system, and the other is a potentially increasing technological 
specialization of the Chinese economy and of Chinese firms. As a quality measure for 
international comparisons, we prefer the most restrictive ISR index 1 because it is only based 
on foreign citations. As such it is not influenced by the expansion of the Chinese patent 
system. In a rapidly expanding system it is possible that the economic value of a single 
citation is declining. In general, it would be possible to include second-order citations in our 
index. Second-order citations attribute higher value to a citation if the citing application itself 
is more highly cited. Citations from within China could be weighted by how many foreign 
citations the citing application has received. However, second-order citations have the 
disadvantage of requiring two adjacent citations windows, which restricts analysis to older 
applications. An alternative procedure for quality analysis is to collect outside information 
about the economic value of a citation, which would provide an anchor to the real economy. 
However, such outside information can only be obtained through expensive surveys. It is an 
advantage of the ISR indices that they are only derived from publicly available patent 
information and are therefore readily available for large-scale analysis. 
It is evident that the three quality indices show different pictures of the evolution of 
quality. Which indicator is the right one? A priori, there are no good or bad citations and there 
is not a single best way of counting citations. Our quality indices provide a full picture of 
patent quality when taken together. The divergent results call for caution when interpreting 
citation-based indices. One must be very careful about which sets of citations to include and 
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which ones to exclude. Furthermore, the indices should not be interpreted in isolation but in 
conjunction with knowledge about the respective economy. 
5.2 PCT applications of Chinese listed firms 
In this section, we narrow our analysis to PCT applications filed by Chinese listed firms 
(Table 3). We observe 5,184 patent filings between 2001 and 2009. As firms are more 
responsive to patent subsidies than individuals, universities, or public research institutes, the 
jump between 2008 and 2009 is especially pronounced. In comparison to Table 2, average 
index values are higher, indicating that PCT applications of listed firms are of higher quality 
than the Chinese average.9 In the most inclusive specification (ISR index 3), the index reaches 
increasingly high values in recent years – summing to an average of 1.44. If we add the 
multiplicative correction factor of 11% for potential language bias the index reaches 160% of 
the global average.  
Because 59% of PCT applications by listed firms originate from ZTE, we recalculate 
the Table 2 without ZTE. Interestingly, the averages of the most restrictive index, considering 
non-self citations from outside own country, increases to 0.54 while the index that includes 
self-citations increases to 0.91. Thus, both indices suggest that PCT applications filed by ZTE 
are of lower average quality. However, the least restrictive index decreases to 1.1 when ZTE 
is excluded – suggesting that, on average, PCT applications by ZTE self-cite more frequently 
than the average PCT application of listed firms. This is not necessarily detrimental to quality; 
prior work has found self-cites to be closely related with firm value (Hall et al. 2005). It 
seems that from 2004 onward ZTE consistently filed PCT applications, and it again 
intensified PCT filings in 2009 in response to PCT subsidies.  
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
9 Again, Table A2 in the Appendix provides detailed information on average citation rates for Chinese patents 
and for the international benchmark.  
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5.3 Large applicants and technology leaders 
Based on our observation that certain firms are influential in determining the quality index – 
and thereby relevant to the transition towards a knowledge-based economy – we investigate 
firms leading in size or technology in Table 4.10 Each applicant is assigned to the main 
technology area in which it has the highest share of PCT applications. Reflective of its size, 
ZTE dominates electrical engineering with an exceptionally large PCT stock of 3,084 
applications. Tsinghua Tongfang is the largest firm in instruments, Sinopec in chemistry, 
Sany in process engineering, Gree in mechanical engineering, and Haier in consumer goods 
and construction. Even though Tsinghua Tongfang is the largest applicant in its main 
technology, the firm still exhibits a quality index of approximately 100% while the remaining 
firms rank lower.  
Regarding China’s technology leaders, we consider those firms with a minimum PCT 
stock greater than five applications. Irtouch leads in electrical engineering, Tsinghua 
Tongfang in instruments, OTIC in chemistry, Sany in process engineering, Longyuan 
Technology in mechanical engineering, and Hisense in consumer goods and construction. In 
contrast to the largest applicants, technology leaders own smaller but more valuable patent 
stocks – 5 out of 6 firms exhibit a quality index above 100%. Also, differentiation of filing 
strategies according to firm size becomes apparent. Whereas OTIC is a relatively small, 
specialized supplier of the electronics industry and has small domestic and PCT stocks, 
Hisense – as established firm in consumer goods – has a large domestic stock but files PCT 
applications selectively. 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
10 In the years after 2009, more firms increased the number of PCT filings. Because we need a 3-year time-
period for the quality measure, we cannot take these developments into account. 
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5.4 Influence of firm characteristics on patent quality 
In this section we investigate the influence of firm characteristics on patent quality (Table 5). 
In our panel of firm-year observations, we measure quality as the firms’ mean ISR index in a 
respective priority year. The main regressors at the firm level correspond to the variables 
presented in Table 1. In addition, we control for annual macro-economic shocks, provincial 
GDP per capita to capture regional differences in China’s economic development, and 
industry-specific effects. A Tobit model with standard errors clustered at the firm level is 
estimated and the average marginal effects are reported to the right side of coefficients.  
In Model (1) our dependent variable is our most restrictive ISR index, which considers 
non-self citations from outside own country. The variable has a mean of 0.45 which differs 
from the total mean of 0.36 in Table 3 because the change in the level of observations from 
patent to firm-year level implies a different weighting. Patents of firms with a high number of 
annual filings obtain a smaller weight. We confirm a positive effect (p<0.01) for the R&D 
stock and a positive effect (p<0.01) for the PCT stock but a negative effect (p<0.05) for the 
domestic patent stock. Precisely, a 1% increase in the stock of R&D expenditures corresponds 
to an increase in the quality index by 0.04 points. Adding one unit to the PCT stock (scaled by 
thousand employees) increases the index by 0.05 points, whereas adding one unit to the 
domestic patent stock (scaled by thousand employees) decreases the index by 0.001 points.  
Thus, our results suggests a positive and economically important relation between 
R&D input as well as PCT intensity and patent quality, whereas the negative marginal effect 
of domestic patenting intensity is rather small. Nonetheless, opposite signs of the PCT stock 
and the domestic patent stock point to key differences in firms’ patenting strategies. While 
firms with higher PCT intensities file PCT patents of higher quality, firms with higher 
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domestic patent intensities may consider patenting rather as a source of subsidy income with 
detrimental consequences for the quality of PCT applications.11  
Except for the year dummy 2009, the coefficients of the remaining firm level 
regressors and control variables are not significant. The negative effect (p<0.1) for 2009 
coincides with the introduction of PCT subsidies by the central government and corresponds 
to a relatively large 1.0-point reduction in the index. In line with the sizable expansion in PCT 
applications between 2008 and 2009, it seems plausible that the increase in quantity causes a 
decrease in quality.  
In Model (2) we change the dependent variable to allow for citations from the 
applicant’s home country. The relationship between the R&D stock and PCT quality turns 
insignificant – suggesting that a sizable R&D input is necessary to produce inventions that are 
built upon by foreign firms but it is not necessary to achieve follow-on inventions by Chinese 
firms. The PCT stock remains positive but declines in significance (p<0.05): an increase by 
one unit only results in an increase by 0.02 points. Further, the domestic patent stock turns 
insignificant. In combination with the significant negative sign of the domestic patent stock in 
Model (1), this result suggests that own-country ISR citations are a less strict quality measure 
compared to ISR citation from abroad. All remaining regressors are insignificant.  
Finally, in Model (3) we allow the quality index to consider all citations, including 
self-citations of the firm. Again, the PCT stock remains positive but declines further in 
significance (p<0.1): an increase by one unit only results in an increase of the quality index by 
0.02 points. It is not surprising that larger firms have a significantly higher index. Firms of 
larger size have a higher probability of citing own PCT patents because they typically have a 
larger existing patent stock. Interestingly, the year dummy for 2009 turns positive as subsidies 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
11 In 2014, listed firms received more than 15 billion USD in subsidies, with patent-related payments reported as 
the most frequent source of subsidy income (21st Century Business Herald, April 30, 2015). 
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for PCT patents motivate firms to file more PCT patents that often cite PCT patents within the 
firm’s patent stock.  
We conduct two robustness tests. Firstly, due to a high correlation of 0.7 between both 
patent stocks, we re-estimate all models excluding the domestic patent stock. In the modified 
specifications, pairwise correlation between all regressors is around 0.4 or lower and the 
regression results remain very similar. Secondly, we exclude ZTE as it is by far the largest 
applicant. Again, we obtain robust results but in Model (3) the year dummy for 2009 turns 
insignificant. This change suggests that the positive and significant effect was driven by 
ZTE’s response to PCT subsidies introduced in 2009 – ZTE filed more patents that generated 
more self-citations.12 Overall, the estimations presented in Table 5 shed light on the question 
of how firm characteristics and the changing economic environment of firms influence patent 
quality.  
6 Conclusions 
Our novel index compares the quality of PCT applications by considering the number of ISR 
citations received by a set of applications from one country to the number of ISR citations 
received by applications of the same priority year and technology class from other countries. 
In its most restrictive variation, e.g. excluding citations form the home country and self-
citations, the ISR index is not biased by selectivity in filing strategies, differences in citations 
due to varying national examination procedures, and domestic economic policy. Thereby, our 
index substantially improves upon earlier measures of patent quality.  
Observing strong increases in Chinese patenting between 2001 and 2009, we compare 
the quality of Chinese PCT applications with those from high-income countries. The quality 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
12 Note that subsidies for PCT grants are only applicable for small and medium sized firms since 2012 (Ministry 
of Finance 2012) , which can be interpreted as an effort to balance the dominance of large applicants in Chinese 
PCT applications. 
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level of Chinese PCT applications achieves only 34% of the quality level of international PCT 
applications and decrease over time. Our results confirm that China’s rise in international 
patenting was achieved to the detriment of quality. Against this background, we find that the 
patent quality of firms, as measured by the strictest ISR index, increases with R&D stocks but 
decreases with the introduction of PCT subsidies.  
Whereas our index has a wide applicability, its main advantage lies in quality 
comparisons among countries or firms with respect to an international benchmark, which can 
be adjusted according to the question of interest. For example, the index allows for quality 
comparisons between the USA and China or between leading MNCs, such as Apple and 
Samsung. In addition, specific technology fields can be analyzed. For example, countries or 
firms can be compared with respect to patent quality in green technology. Further, the index is 
particularly useful for ex-post policy evaluation if it cannot be ruled out that the policy 
influences the behavior of the national patent office, a situation which applies to China. Our 
index improves upon quality measures of patent applications that are currently in use, e.g. 
counting of triadic patent families and standard citation measures. 
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Tables and Figures 
Table 1: Firm characteristics 
Variable Mean Median Std. Dev. Min Max Obs. 
R&D stock (million RMB) 487.89 30.45 2,184 0 25,001 451 
PCT stock/‘000 employees 3.443 0.825 8.443 0.005 100 451 
Domestic stock/‘000 employees 55.26 8.589 217.0 0 2,920 451 
Employees 20,237 3,126 68,680 10 539,168 451 
Firm age 11.49 11 5.057 1 29 451 
Private ownership 0.417 0 0.494 0 1 451 
 
Note: Statistics based on firms with at least one PCT application. 
 
 
 
 
Table 2: PCT applications of Chinese origin  
 ISR index 1 
ISR 
index 2 
ISR 
index 3 Obs. 
Considered citations     
Applicant country excluded included included  
Self-cites excluded excluded included  
2001 0.478 0.390 0.375 793 
2002 0.373 0.338 0.313 1,060 
2003 0.403 0.362 0.327 1,368 
2004 0.349 0.281 0.323 1,948 
2005 0.429 0.403 0.459 3,321 
2006 0.315 0.430 0.523 4,649 
2007 0.290 0.558 0.732 5,799 
2008 0.299 0.768 1.138 6,159 
2009 0.335 0.904 1.536 9,641 
Total 0.335 0.626 0.913 34,738 
 
Note: Analysis at patent level. Mean values of variables displayed. 
 
 
  
31 
 
Table 3: PCT applications of Chinese listed firms 
 ISR index 1 
ISR 
index 2 
ISR 
index 3 Obs. 
Considered citations     
Applicant country excluded included included  
Self-cites excluded excluded included  
2001 0.608 0.859 0.949 53 
2002 0.576 0.574 0.692 102 
2003 0.429 0.538 0.492 159 
2004 0.844 0.811 0.704 195 
2005 0.580 0.731 0.588 347 
2006 0.586 0.650 0.702 429 
2007 0.507 0.834 1.164 710 
2008 0.252 0.705 1.668 871 
2009 0.220 0.727 1.877 2,318 
Total 0.360 0.727 1.441 5,184 
 
Note: Analysis at patent level. Mean values of variables displayed. 
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Table 4: Comparison of largest firms and technology leaders 
 Largest applicant Technology leader 
Main technology area Firm PCT stock CN stock ISR index Firm PCT stock CN stock ISR index 
Electrical engineering ZTE 3,084 13,942 0.237 Irtouch  13 32 1.912 
Instruments Tsinghua Tongfang 64 781 1.073 Tsinghua Tongfang 64 781 1.073 
Chemistry Sinopec 117 3,770 0.471 OTIC 7 6 3.32 
Process engineering Sany 75 542 0.849 Sany 75 542 0.849 
Mechanical engineering Gree 69 1,013 0 Longyuan Power 8 42 1.713 
Consumer goods and construction Haier 35 2,497 0.700 Hisense 7 1,682 2.014 
 
Note: Mean values of ISR index 1 shown. Analysis at patent level. To ensure a minimum size of the PCT stock, technology leaders are required to have a PCT stock > 5. Full 
names of firms are as follows: ZTE Zhongxing Telecommunication Equipment Corporation, Tsinghua Tongfang Company, SINOPEC China Petroleum & Chemical 
Corporation, Sany Heavy Industry Corporation, Gree Electric Appliances Incorporated, Haier Group,, Irtouch Systems, OTIC Ningxia Orient Tantalum Industry Corporation, 
Longyuan Power Group Corporation, and Hisense Corporation. 
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Table 5: Tobit estimations on ISR index 
 (1) (2) (3) 
 ISR index 1 ISR index 2 ISR index 3 
Considered citations    
Applicant country excluded included included 
Self-cites excluded excluded included 
ln(R&D stock) 0.180*** 
(0.064) 
[0.037] 
 
0.039 
(0.035) 
[0.011] 
 
-0.004 
(0.026) 
[-0.001] 
 
PCT patent stock /‘000 employees 0.239*** 
(0.050) 
[0.049] 
 
0.085** 
(0.043) 
[0.024] 
 
0.055* 
(0.028) 
[0.019] 
 
Domestic patent stock/‘000 employees -0.006** 
(0.003) 
[-0.001] 
 
-0.001 
(0.002) 
[-0.0003] 
 
-0.001 
(0.001) 
[-0.0003] 
 
ln(employees) 0.252 
(0.237) 
[0.051] 
 
0.206 
(0.151) 
[0.058] 
 
0.221** 
(0.098) 
[0.077] 
 
ln(age) -0.827 
(0.688) 
[-0.169] 
 
-0.144 
(0.450) 
[-0.040] 
 
-0.022 
(0.300) 
[-0.008] 
 
Private ownership 0.825 
(0.687) 
[0.169] 
 
-0.113 
(0.459) 
[-0.032] 
 
-0.052 
(0.304) 
[-0.018] 
 
2002 -1.587 
(2.355) 
[-0.426] 
 
-1.211 
(1.629) 
[-0.359] 
 
-0.809 
(1.079) 
[-0.238] 
 
2003 -2.611 
(2.439) 
[-0.656] 
 
-2.128 
(1.536) 
[-0.585] 
 
-1.376 
(1.032) 
[-0.379] 
 
2004 -0.559 
(2.258) 
[-0.16] 
 
-1.410 
(1.560) 
[-0.411] 
 
-0.354 
(0.977) 
[-0.110] 
 
2005 -2.147 
(2.159) 
[-0.556] 
 
-2.163 
(1.444) 
[-0.593] 
 
-1.261 
(0.959) 
[-0.352] 
 
2006 -2.273 
(2.294) 
[-0.584] 
 
-1.367 
(1.509) 
[-0.400] 
 
-0.346 
(0.992) 
[-0.108] 
 
2007 -3.300 
(2.501) 
[-0.795] 
 
-1.658 
(1.572) 
[-0.474] 
 
-0.518 
(1.043) 
[-0.158] 
 
2008 -3.340 
(2.445) 
[-0.803] 
 
0.168 
(1.508) 
[0.056] 
 
0.827 
(0.995) 
[0.298] 
 
2009 -4.198* 
(2.321) 
[-0.958] 
 
-0.392 
(1.508) 
[-0.124] 
 
1.706* 
(0.994) 
[0.687] 
 
ln(provincial GDP/capita) -0.733 
(0.654) 
[-0.150] 
 
-0.265 
(0.458) 
[-0.074] 
 
-0.458 
(0.349) 
[-0.159] 
 
Industry controls Yes  Yes  Yes  
Observations (firms) 451 (228)  451 (228)  451 (228)  
Log pseudo likelihood -348.87  -550.58  -615.78  
 
Note: Analysis at firm level. The dependent variable is the average ISR index of the annual patent applications. 
Tobit analysis with standard errors clustered at the firm level. Average marginal effects are reported in square 
brackets. Reference category for year is 2001, for industry it is remaining, and for region it is Coast. *** sig. 
level < 1%, ** sig. level < 5%, * sig. level < 10%. 
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Figure 1: PCT applications by country of origin 
 
Sources: WIPO 2014a 
 
 
Figure 2: Expansion of patent ownership in Chinese firms 
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Appendix 
 
 
Table A1: PCT applications of Chinese origin  
 Chinese patents 1 
Chinese 
patents 2 
Chinese 
patents 3 
Bench-
mark 1 
Bench-
mark 2 
Bench-
mark 3 Obs. 
Considered citations        
Applicant country excluded included included excluded included included  
Self-cites excluded excluded included excluded excluded included  
2001 0.131 0.165 0.217 0.269 0.414 0.576 793 
2002 0.079 0.108 0.144 0.243 0.362 0.517 1,060 
2003 0.085 0.112 0.147 0.236 0.342 0.493 1,368 
2004 0.074 0.088 0.143 0.219 0.313 0.443 1,948 
2005 0.091 0.125 0.199 0.225 0.318 0.437 3,321 
2006 0.073 0.154 0.262 0.253 0.36 0.491 4,649 
2007 0.075 0.235 0.407 0.285 0.41 0.541 5,799 
2008 0.077 0.311 0.627 0.292 0.423 0.573 6,159 
2009 0.076 0.324 0.781 0.281 0.416 0.569 9,641 
Total 0.079 0.233 0.473 0.268 0.389 0.531 34,738
 
Note: Analysis at patent level. Mean values of variables displayed. 
 
 
 
 
Table A2: PCT applications of Chinese listed firms  
 Chinese patents 1 
Chinese 
patents 2 
Chinese 
patents 3 
Bench-
mark 1 
Bench-
mark 2 
Bench-
mark 3 Obs. 
Considered citations        
Applicant country excluded included included excluded included included  
Self-cites excluded excluded included excluded excluded included  
2001 0.132 0.283 0.453 0.273 0.419 0.604 53 
2002 0.118 0.196 0.343 0.269 0.406 0.58 102 
2003 0.094 0.195 0.264 0.257 0.37 0.524 159 
2004 0.185 0.246 0.282 0.232 0.327 0.468 195 
2005 0.107 0.196 0.23 0.225 0.317 0.44 347 
2006 0.14 0.228 0.352 0.251 0.355 0.488 429 
2007 0.131 0.339 0.614 0.281 0.395 0.519 710 
2008 0.065 0.288 0.91 0.287 0.406 0.537 871 
2009 0.050 0.226 0.866 0.258 0.371 0.487 2,318 
Total 0.097 0.253 0.620 0.262 0.374 0.503 5,184 
 
Note: Analysis at patent level. Mean values of variables displayed. 
 
